« Check it out - Tour Now Then Sept. 12 | Main | Taking Control Of Your Diabetes – see Dr. Steve Edelman before the year is out! »

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c9de153ef010534a38aa2970b

Listed below are links to weblogs that reference JDRF Continuous monitoring trial receives big win - reported in Europe and published in the prestigious New England Journal of Medicine:

Comments

Hi,
I think your blog is terrific, and I would like to feature you on Wellsphere (http://www.wellsphere.com). Would you drop me an email?
Good health!
Geoff
--
Geoffrey W. Rutledge, MD, PhD
http://medblog.wellsphere.com

While I agree that having this published in an esteemed medical journal is a step that is badly-needed in securing insurance coverage, I question why the industry selling these devices did not do this research. While some are startups, others are well-capitalized medical conglomerates. For example, the last time I checked, Medtronic, Inc. (maker of one CGMS device) was a $13,515 mil company who could more than afford to pay for these studies. Instead, they leave the research up to a nonprofit like JDRF to foot the cost instead -- shame on diaBusiness!!

As a JDRF fundraiser, I would really prefer that my hard-earned money be going towards the reason the organization was founded: a cure. This is not a cure, but a costly Band-Aid which industry should be footing the cost to justify. However, JDRF's CEO stepped down unexpected earlier this year, so perhaps we may see yet another change in strategy when the organization finally names a new CEO.

The comments to this entry are closed.